Astria Therapeutics Inc
NASDAQ:ATXS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
US |
|
H
|
Haier Smart Home Co Ltd
HKEX:6690
|
CN |
|
I
|
Interface Inc
XBER:IF6N
|
US |
|
B
|
BioLife Solutions Inc
F:BJX1
|
US |
|
P
|
Pebblebrook Hotel Trust
F:PD0
|
US |
|
JAFCO Group Co Ltd
TSE:8595
|
JP |
|
A
|
Air Products and Chemicals Inc
F:AP3
|
US |
|
Kimco Realty Corp
NYSE:KIM
|
US |
|
E
|
Exor NV
OTC:EXXRF
|
NL |
|
C
|
Cashbuild Ltd
XBER:C8J
|
ZA |
|
Unicharm Corp
TSE:8113
|
JP |
|
A
|
Arrow Electronics Inc
LSE:0HI1
|
US |
|
Talanx AG
OTC:TLLXY
|
DE |
|
F
|
Fortinet Inc
XBER:FO8
|
US |
|
Trimble Inc
NASDAQ:TRMB
|
US |
Bankruptcy Probability
Astria Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Astria Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
729.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
444.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
195.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Astria Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Astria Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.